Clinical Trial Update: Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating simvastatin for portal hypertension in compensated cirrhosis. The status of the study is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Portal Hypertension., Liver Cirrhosis | Phase 4 | Status: UNKNOWN